In last trading session, the stock price of Ekso Bionics Holdings, Inc. (OTCMKTS:EKSO) gained more than 15% to close the trading session at $6.17. The gains came at a share volume of 313,480 compared to average share volume of 61,918.
As per the latest update, EksoBionics has gain worldwide connectivity with Vodafone’s ‘IoT’ technology. The telecom carrier will be connecting the FDA approved exoskeleton for use with patients with spinal cord injuries and stroke. Vodafone’s global Internet of Things SIM and network will warrant reliable infrastructures for diagnostics and enhanced access to patient data, thus resulting in improved user experience with the Ekso GT suit.
Robotic exoskeletons are battery-powered robots that are put onover the patients’ clothing, allowing individuals to achieve endurance, mobility, or strength not otherwise possible. Exoskeleton, as designed by Ekso Bionics, can offer adaptive amount of strength to the both side of the user’s body, helping to enhance results for users. It enables physical therapists to help in better mobilization in patients, more frequently, and also with an increased number of intensity steps, which aids recovery.
The management view
Thomas Looby, the CEO of Ekso Bionics, said that they are in business to support patients achieve the remarkable, and this they can achieve most effectively in association with best in-class associates. The CEO added that they selected Vodafone to offer a single global offering that warrants seamless connectivity, irrespective of hospital location.
With IoT technology, they can monitor the performance of exoskeletons in real time, offering therapists with comprehensive data on the patients’ rehabilitation progress. Andrew Morawski of Vodafone Group said that the IoTis allowing seamless connection of medical devices across the globe, which in turn is affecting the level of care offered to patients. Ekso exoskeleton is making a significant different in the quality of life of spinal cord injury and stroke patients.